Address
Seestrasse 16
Kusnacht, 8700
Switzerland
Phone
41 44 267 67 00
Sector
Healthcare
Industry
Biotechnology
Employees
10
First IPO Date
January 04, 2000
| Name | Title | Pay | Year Born |
| Daniel Koller | Head of Biotech, Portfolio Manager and Member of Executive Board | 0 | 1970 |
BB Biotech AG is an investment fund overseen by Bellevue Asset Management AG. This fund allocates capital to publicly traded companies worldwide, with a primary focus on firms pioneering modern biotechnology, specifically in the development of medications and diagnostic tools. The construction of its investment portfolio is guided by a fundamental analysis approach. Established on November 9, 1993, BB Biotech AG is headquartered in Switzerland.